| Typicality: | 0.352 |
| Saliency: | 0.240 |
| randomly | 13 | manner |
| to groups | 3 | other |
| subject → be assigned to → the placebo group | 6 |
| subject → be assigned to → a placebo group | 5 |
| subject → be assigned to → placebo group | 5 |
| subject → be in → the placebo group | 3 |
| negative | neutral | positive |
| 0.165 | 0.804 | 0.031 |
| Raw frequency | 19 |
| Normalized frequency | 0.240 |
| Modifier score | 0.500 |
| Perplexity | 26.548 |